Publication: Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma
Issued Date
2008-10-01
Resource Type
ISSN
01715216
Other identifier(s)
2-s2.0-50249097226
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Cancer Research and Clinical Oncology. Vol.134, No.10 (2008), 1135-1141
Suggested Citation
P. Saelee, S. Wongkham, V. Bhudhisawasdi, B. Sripa, S. Chariyalertsak, S. Petmitr Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. Vol.134, No.10 (2008), 1135-1141. doi:10.1007/s00432-008-0379-1 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/18849
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma
Other Contributor(s)
Abstract
Purpose: To identify and characterize novel genetic alterations in hepatocellular carcinoma (HCC). Methods: DNA was extracted from 29 HCC and corresponding normal tissues and amplified with 59 different 10-base arbitrary primers. A 550 bp DNA fragment amplified using primer Q-9 and which was present in 19 of 29 cases (66%) was cloned, sequenced, and compared with known nucleotide sequences deposited in Genome database, and quantified by real-time PCR. Results: DNA alterations were found on chromosomes 5q34, 6p25.2 and 8q12.1 in 11 of 29 cases (38%), 7 of 29 cases (24%), and 12 of 29 cases (41%), respectively. Multivariate analysis showed that the allelic loss on chromosome 5q34 was an independent prognostic factor for poor survival of HCC patients, with the median survival time of 19 weeks for allelic loss versus 109 weeks for no allelic loss (P = 0.001). Conclusions: This study indicates that allelic loss on chromosome 5q34 may be involved in the development of HCC and could be used as a prognostic indicator in HCC patients. © 2008 Springer-Verlag.